Alzheimers Res Ther 12:149 Golde TE (2016) Overcoming translational barriers impeding development of Alzheimers disease modifying therapies
Nasal formulas from reputable peptide sources have recently become available for researchers to explore this promising means of application, as detailed below
Heffernan MA, Jiang WJ, Thorburn AW, Ng FM: Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism
Semaglutide causes tiredness in 11% of users through caloric deficit and GLP-1 receptor activation
found Tn-immunization protected newborn and adult mice from hyperoxia-induced lung injury by reducing NF-B activity, decreasing markers of oxidative stress, and maintaining pulmonary vascular density
Fluorescent peptide dendrimers for siRNA transfection: tracking pH responsive aggregation, siRNA binding, and cell penetration